The adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment – from preclinical perspectives

Abstract Esophageal cancer (EC) is the fourth and sixth leading cause of cancer-related deaths in China and United States, respectively. The dismal prognosis of EC is mainly attributed to distant metastases, which may not be overcome by chemotherapy alone. Hence, the use of alternative adjuvant trea...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lin Li, Grace Gar-Lee Yue, Julia Kin-Ming Lee, Eric Chun-Wai Wong, Kwok-Pui Fung, Jun Yu, Clara Bik-San Lau, Philip Wai-Yan Chiu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5940634e4bce41e8be9896803c981e5c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5940634e4bce41e8be9896803c981e5c
record_format dspace
spelling oai:doaj.org-article:5940634e4bce41e8be9896803c981e5c2021-12-02T16:06:03ZThe adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment – from preclinical perspectives10.1038/s41598-017-00934-x2045-2322https://doaj.org/article/5940634e4bce41e8be9896803c981e5c2017-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-00934-xhttps://doaj.org/toc/2045-2322Abstract Esophageal cancer (EC) is the fourth and sixth leading cause of cancer-related deaths in China and United States, respectively. The dismal prognosis of EC is mainly attributed to distant metastases, which may not be overcome by chemotherapy alone. Hence, the use of alternative adjuvant treatments, such as herbal medicines, for metastatic EC remains a great desire of patients. Our previous study demonstrated the in vivo anti-tumor and in vitro anti-invasion activities of Andrographis paniculata (AP) in esophageal cancer. In the present study, the chemical constituents of absorbed AP components through human intestinal Caco-2 cell monolayer were verified for the first time. The anti-migratory activities and suppressive effects on metastasis-related factors such as HER2, MMP2, MMP9, TM4SF3, CXCR4 of the absorbed AP components were revealed in esophageal cancer cells EC-109. The anti-tumor and anti-metastatic effects of AP water extract (1600 mg/kg) were further confirmed in metastatic esophageal xenograft-bearing mice. Besides, AP water extract acted synergistically with cisplatin plus 5-fluorouracil on inhibiting tumor nodule growth (with combination index <0.7). Meanwhile, chemotherapeutics-induced side-effects could also be reduced by AP water extract. The present findings provide evidence on safety and advantages of the combined use of AP with chemotherapeutics in pre-clinical setting.Lin LiGrace Gar-Lee YueJulia Kin-Ming LeeEric Chun-Wai WongKwok-Pui FungJun YuClara Bik-San LauPhilip Wai-Yan ChiuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Lin Li
Grace Gar-Lee Yue
Julia Kin-Ming Lee
Eric Chun-Wai Wong
Kwok-Pui Fung
Jun Yu
Clara Bik-San Lau
Philip Wai-Yan Chiu
The adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment – from preclinical perspectives
description Abstract Esophageal cancer (EC) is the fourth and sixth leading cause of cancer-related deaths in China and United States, respectively. The dismal prognosis of EC is mainly attributed to distant metastases, which may not be overcome by chemotherapy alone. Hence, the use of alternative adjuvant treatments, such as herbal medicines, for metastatic EC remains a great desire of patients. Our previous study demonstrated the in vivo anti-tumor and in vitro anti-invasion activities of Andrographis paniculata (AP) in esophageal cancer. In the present study, the chemical constituents of absorbed AP components through human intestinal Caco-2 cell monolayer were verified for the first time. The anti-migratory activities and suppressive effects on metastasis-related factors such as HER2, MMP2, MMP9, TM4SF3, CXCR4 of the absorbed AP components were revealed in esophageal cancer cells EC-109. The anti-tumor and anti-metastatic effects of AP water extract (1600 mg/kg) were further confirmed in metastatic esophageal xenograft-bearing mice. Besides, AP water extract acted synergistically with cisplatin plus 5-fluorouracil on inhibiting tumor nodule growth (with combination index <0.7). Meanwhile, chemotherapeutics-induced side-effects could also be reduced by AP water extract. The present findings provide evidence on safety and advantages of the combined use of AP with chemotherapeutics in pre-clinical setting.
format article
author Lin Li
Grace Gar-Lee Yue
Julia Kin-Ming Lee
Eric Chun-Wai Wong
Kwok-Pui Fung
Jun Yu
Clara Bik-San Lau
Philip Wai-Yan Chiu
author_facet Lin Li
Grace Gar-Lee Yue
Julia Kin-Ming Lee
Eric Chun-Wai Wong
Kwok-Pui Fung
Jun Yu
Clara Bik-San Lau
Philip Wai-Yan Chiu
author_sort Lin Li
title The adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment – from preclinical perspectives
title_short The adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment – from preclinical perspectives
title_full The adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment – from preclinical perspectives
title_fullStr The adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment – from preclinical perspectives
title_full_unstemmed The adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment – from preclinical perspectives
title_sort adjuvant value of andrographis paniculata in metastatic esophageal cancer treatment – from preclinical perspectives
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/5940634e4bce41e8be9896803c981e5c
work_keys_str_mv AT linli theadjuvantvalueofandrographispaniculatainmetastaticesophagealcancertreatmentfrompreclinicalperspectives
AT gracegarleeyue theadjuvantvalueofandrographispaniculatainmetastaticesophagealcancertreatmentfrompreclinicalperspectives
AT juliakinminglee theadjuvantvalueofandrographispaniculatainmetastaticesophagealcancertreatmentfrompreclinicalperspectives
AT ericchunwaiwong theadjuvantvalueofandrographispaniculatainmetastaticesophagealcancertreatmentfrompreclinicalperspectives
AT kwokpuifung theadjuvantvalueofandrographispaniculatainmetastaticesophagealcancertreatmentfrompreclinicalperspectives
AT junyu theadjuvantvalueofandrographispaniculatainmetastaticesophagealcancertreatmentfrompreclinicalperspectives
AT clarabiksanlau theadjuvantvalueofandrographispaniculatainmetastaticesophagealcancertreatmentfrompreclinicalperspectives
AT philipwaiyanchiu theadjuvantvalueofandrographispaniculatainmetastaticesophagealcancertreatmentfrompreclinicalperspectives
AT linli adjuvantvalueofandrographispaniculatainmetastaticesophagealcancertreatmentfrompreclinicalperspectives
AT gracegarleeyue adjuvantvalueofandrographispaniculatainmetastaticesophagealcancertreatmentfrompreclinicalperspectives
AT juliakinminglee adjuvantvalueofandrographispaniculatainmetastaticesophagealcancertreatmentfrompreclinicalperspectives
AT ericchunwaiwong adjuvantvalueofandrographispaniculatainmetastaticesophagealcancertreatmentfrompreclinicalperspectives
AT kwokpuifung adjuvantvalueofandrographispaniculatainmetastaticesophagealcancertreatmentfrompreclinicalperspectives
AT junyu adjuvantvalueofandrographispaniculatainmetastaticesophagealcancertreatmentfrompreclinicalperspectives
AT clarabiksanlau adjuvantvalueofandrographispaniculatainmetastaticesophagealcancertreatmentfrompreclinicalperspectives
AT philipwaiyanchiu adjuvantvalueofandrographispaniculatainmetastaticesophagealcancertreatmentfrompreclinicalperspectives
_version_ 1718385149060579328